Ethics statement The studies involving human participants were reviewed and approved by Ethics Committee of the Anhui Provincial Mental Health Center

Muscle Cramping on GLP-1 Drugs: Which Medications Cause or Treat It At a glance Muscle cramps affect an estimated 2-4% of GLP-1 users in clinical trial populations GI side effects (nausea, vomiting, diarrhea) drive electrolyte depletion, the primary cramp trigger Magnesium, potassium, and sodium losses are the most common electrolyte deficits involved Diuretics, statins, and PPIs co-prescribed with GLP-1s compound cramping risk Rapid weight loss at rates above 1 kg per week increases muscle-related complaints Lab panel (BMP, magnesium, phosphorus) is the first diagnostic step Magnesium glycinate 200-400 mg nightly is a first-line supplement intervention Most cramps resolve within 2-4 weeks of targeted electrolyte correction Dose reduction or slower titration of the GLP-1 may be necessary in refractory cases Why GLP-1 Drugs Trigger Muscle Cramps Muscle cramping during GLP-1 receptor agonist therapy is not a direct pharmacologic effect of the drug on skeletal muscle

60 capsules 60-day supply at 1 capsule per day
The clinic business address is 17322 Murphy Avenue, Irvine, California 92614
The development of easy-to-assemble platform products led Ypsomed to collaborate with a group of leading assembly equipment manufacturers (Figure 4)
Administration Guidance: Our staff will guide you through the administration process and provide ongoing support to ensure proper use and preservation of muscle mass